The evaluation of gene polymorphisms associated with autoinflammatory syndrome in patients with palindromic rheumatism complicated by intermittent hydrarthrosis.


Journal

Clinical rheumatology
ISSN: 1434-9949
Titre abrégé: Clin Rheumatol
Pays: Germany
ID NLM: 8211469

Informations de publication

Date de publication:
Mar 2020
Historique:
received: 29 05 2019
accepted: 09 12 2019
revised: 12 11 2019
pubmed: 4 1 2020
medline: 6 1 2021
entrez: 4 1 2020
Statut: ppublish

Résumé

Palindromic rheumatism (PR) is a type of acute arthritis or periarthritis characterized by recurrence, paroxysmal, or intermittent disease attacks and occasionally progresses to other types of rheumatic disease. PR patients who are anti-citrullinated protein antibodies (ACPA)-negative have a high prevalence of MEFV gene polymorphisms, and intermittent hydrarthrosis (IH) is also associated with MEFV polymorphisms. The purpose of this study was to evaluate the clinical characteristics of and autoinflammatory syndrome-associated gene polymorphisms in patients with PR and IH and to identify predictive factors for developing other rheumatic diseases. Six PR patients (four females; median age at disease onset, 20.0 years; median age at evaluation, 47.0 years) were retrospectively evaluated for clinical features and polymorphisms in genes responsible for autoinflammatory diseases. All six patients fulfilled the diagnostic criteria for PR and showed clinical feature of IH. Two presented with recurrent fever. All six patients were negative for rheumatoid factor and ACPA and had normal articular X-ray findings. Among the six patients, MEFV gene polymorphisms known to cause FMF were identified in four, CIAS1 mutation was observed in one, and TNFRSFIA mutation was observed in one. Colchicine was effective in three patients with MEFV polymorphisms. The other five patients continued to experience PR, although three patients achieved remission with medication. PR presenting with IH might be associated with gene polymorphisms responsible for autoinflammatory diseases; colchicine appears to be effective in these patients.Key Point• Palindromic rheumatism with intermittent hydrarthrosis might be associated with gene polymorphisms responsible for autoinflammatory diseases.

Identifiants

pubmed: 31897954
doi: 10.1007/s10067-019-04883-w
pii: 10.1007/s10067-019-04883-w
doi:

Substances chimiques

Anti-Inflammatory Agents, Non-Steroidal 0
MEFV protein, human 0
Pyrin 0
Colchicine SML2Y3J35T

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

841-845

Références

Br Med J. 1957 Jan 19;1(5011):139-43
pubmed: 13383213
Ann Rheum Dis. 2013 Jan;72(1):155
pubmed: 22887853
Ann Rheum Dis. 2015 Apr;74(4):635-41
pubmed: 25628446
J Rheumatol. 2014 Aug;41(8):1650-5
pubmed: 25028368
Nihon Rinsho Meneki Gakkai Kaishi. 2011;34(5):355-60
pubmed: 22041422
J Rheumatol. 1999 Mar;26(3):540-5
pubmed: 10090159
Am J Med. 1992 Oct;93(4):451-60
pubmed: 1341421
Arthritis Rheum. 2007 Aug;56(8):2784-8
pubmed: 17665427
Arthritis Rheum. 2006 Jul;54(7):2334-5
pubmed: 16802374
Medicine (Baltimore). 2014 May;93(3):158-64
pubmed: 24797171
Arthritis Res Ther. 2014 Sep 27;16(5):439
pubmed: 25261100
Medicine (Baltimore). 2012 Nov;91(6):337-43
pubmed: 23111802
Calif Med. 1949 Nov;71(5):359-61
pubmed: 15390577
Scand J Rheumatol. 1987;16(6):413-20
pubmed: 3423751
Rheumatology (Oxford). 2003 Feb;42(2):391-2
pubmed: 12595650
Nat Immunol. 2013 May;14(5):454-60
pubmed: 23502856
Arthritis Rheum. 1997 Oct;40(10):1879-85
pubmed: 9336425

Auteurs

Yumi Tani (Y)

Department of Rheumatology, School of Medicine, Tokyo Women's Medical University, 8-1, Kawada-cho, Shinjuku-ku, Tokyo, 162-8666, Japan.

Takayuki Kishi (T)

Department of Rheumatology, School of Medicine, Tokyo Women's Medical University, 8-1, Kawada-cho, Shinjuku-ku, Tokyo, 162-8666, Japan. kishi.takayuki@twmu.ac.jp.
Department of Pediatrics, School of Medicine, Tokyo Women's Medical University, 8-1, Kawada-cho, Shinjuku-ku, Tokyo, 162-8666, Japan. kishi.takayuki@twmu.ac.jp.

Takako Miyamae (T)

Department of Rheumatology, School of Medicine, Tokyo Women's Medical University, 8-1, Kawada-cho, Shinjuku-ku, Tokyo, 162-8666, Japan.

Manabu Kawamoto (M)

Department of Rheumatology, School of Medicine, Tokyo Women's Medical University, 8-1, Kawada-cho, Shinjuku-ku, Tokyo, 162-8666, Japan.

Yasushi Kawaguchi (Y)

Department of Rheumatology, School of Medicine, Tokyo Women's Medical University, 8-1, Kawada-cho, Shinjuku-ku, Tokyo, 162-8666, Japan.

Atsuo Taniguchi (A)

Department of Rheumatology, School of Medicine, Tokyo Women's Medical University, 8-1, Kawada-cho, Shinjuku-ku, Tokyo, 162-8666, Japan.

Hisashi Yamanaka (H)

Department of Rheumatology, School of Medicine, Tokyo Women's Medical University, 8-1, Kawada-cho, Shinjuku-ku, Tokyo, 162-8666, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH